Infection Control for Safe Environments
SteriLumen was founded in 2016 to provide novel, easy to deploy and effective devices to protect vulnerable populations from dangerous infections.
Our engineers create patented products that manage infection control for safe environments. We employ proven germicidal UVC in a variety of automated and connected designs, rising to meet the disinfection challenges in our most important industries.
Our guiding principle is to create safe environments without emission of ozone or other chemicals, and provide the modern convenience of connected, remote asset management capabilities that enable Data Driven Disinfection™.
In February 2021 we acquired Akida LLC, makers of the Airocide™ product line which was developed with NASA to address air-borne pathogens and bring market-leading air purification technology to the fight against coronavirus. Together, our advanced designs and infection control for safe environment technologies significantly lower the risk of infection, controlling outbreaks and allowing businesses to get back to what they do best. We are a wholly owned subsidiary of Applied UV Inc. (NASDAQ:AUVI).
Chief Executive Officer
A seasoned CEO and senior executive with a record of achievement in sales, marketing and operations development, strategic planning, and business development. Mr. Saeed recently was CEO of Ubiquity LLC and advised the National Mental Health Innovation Center (NMHIC), worked with CU Innovations on business partnerships and co development with their technology innovation network (TIN) on virtual and augmented reality to conduct interventions and training protocols at the University of Colorado Anschutz Medical Center.
Previously, in 2016 he was founder and CEO of Vital Neuro, Inc. which has converged machine learning and cloud technologies in a closed feedback system. Vital Neuro is an evidence based, proven service relieving employee stress with a personalized 15 minute daily sessions through an connected app.
Prior to that and until the end of 2015 Mr. Saeed spent three and a half years at Kymeta Corporation, a Bill Gates company, as the EVP of strategy and development creating a market approach to the connected car strategy, sourcing and securing unique raw materials and industry relations and partnerships.
Among several smaller startups, Mr. Saeed Co-founded Open Range Communications in 2004 to deliver broadband to rural and underserved communities in the US. In 2001 Mr. Saeed was instrumental in the launch of the first cellular Blackberry at T-Mobile USA where he was part of the pioneering team introducing the first device converging voice and data to the market in 2001. He worked at AT&T wireless advanced services organization introducing CDPD and converged wireless data through 1999.
Chief Operating Officer
Mr. Doyle has over 28 years’ experience in general management, operations, marketing, sales and consulting.
Most recently, Mr. Doyle was the President of Panasonic Enterprise Solutions company, a $450 million solution and engineering company focused primarily on North America, but with limited clients in Asia and Europe. This company built complex solutions for Panasonic’s global customers in sports and entertainment, energy, and smart city industries. His clients ranged from the Philadelphia Eagles to MGM to the US Government.
Before joining Panasonic, Mr. Doyle was a Consulting Partner with IBM Global Business Services leading its North American Electronics industry solutions unit, the final role in a thirteen-year span with IBM.
Mr. Doyle currently serves on the board of Mobilitynext, a nonprofit organization that brings public and private entities together to solve the world’s most challenging transportation and mobility challenges.
Mr. Doyle also served as an Officer in the US Marine Corps, participating in Operation Restore Hope in Somalia. Mr. Doyle has an MBA in Marketing and Decision & Information Systems from Indiana University and a BS in Marketing from Syracuse University.
Vice President, Marketing & Corporate Development
Ms. Wallen’s track record in life sciences spans over 20 years with leadership roles in both large multinationals and start-up companies.
She was most recently head of Corporate Development at Terumo BCT, the $1 billion biomedical division of Terumo Corporation (4543.T-JP:TokyoSE), with responsibility for partnerships to augment the division’s products and technologies for life-saving blood and cell-based therapies.
Previously she served as Chief Operating Officer of Andarix Pharmaceuticals, a clinical stage oncology therapeutics company, and President/CEO of Caveo Therapeutics, a biotechnology company with reagent and therapeutic antibody product lines. In consulting roles with Cygnet Venture Management, she served as interim management for senior level business development and marketing functions, working with life science CEOs and founders and helping clients raise over $30M.
Ms. Wallen was formerly an investment professional with Sequel Venture Partners and is a Director of Ekso Bionics (Nasdaq: EKSO), and Boulder Community Health.
Vice President, Global Sales
Mr. Berger most recently served as vice president of strategy and go-to-market at Zivaro, Inc., a provider of consulting and technology services, where he successfully refactored the analytics business and delivered significant revenue growth and margin expansion.
During his tenure at Zivaro, Mr. Berger’s sales performance and related strategic initiatives were recognized with awards for Manager of the Year, Enterprise Sales Team of the Year, Community Volunteer of the Year and Presidents Club.
Prior to Zivaro, Mr. Berger was a Managing Director at Hughes Cloud Services, where he was recruited by the president to build the business plan, go-to-market strategy, and branding with overall responsibility for sales, marketing, partner, product, and corporate development. Before joining Hughes Cloud Services, he served in executive sales leadership roles for numerous companies, including Credera Inc., Viawest, Inc. and T-Mobile USA.
Mr. Berger was a past Board Chair Associate Board of Directors for Big Brothers Big Sisters of Colorado and has served on numerous steering committees of the Colorado Technology Association. He is a graduate of the University of Colorado, Boulder and holds a bachelor’s degree in International Affairs.
Board of DirectorsApplied UV Inc.
Dr. Eugene A. Bauer
In 2010, Dr. Bauer co-founded Dermira, a publicly traded specialty biopharmaceutical company acquired by Eli Lilly and Company in 2020.
Alastair J. Clemow, Ph.D.
Dr. Clemow currently serves as Chairman of Ensemble Orthopedics, an early-stage company developing an innovative pyrocarbon finger joint for the treatment for early state osteoarthritis.
Dallas C. Hack, M.D., M.P.H.
Dr. Hack is board certified in General Preventive Medicine and Public Health, and a Fellow in the American College of Military Public Health.
Eugene E. Burleson
Mr. Burleson is a private investor. He served as Chairman of PET DRx Corporation from June 2005 to July 1, 2010, and its Chief Executive Officer from October 2008 until its acquisition by VCA Antech in July 2010.